Partner and member of Catalyst’s investment committee. Actively involved in all aspects of Fund Management including Investments and Capital Raising. Led Catalyst’s investments in Augmenix Inc. (Acquired by Boston Scientific, NYSE: BSX), nVision Medical (Acquired by Boston Scientific, NYSE: BSX), Maxwell Health (Acquired by Sun Life Financial, NYSE: SLF), Lantos Technologies, Aria CV, Atacor Medical, Panther Therapeutix and Instylla Inc. Actively involved with prior portfolio company Allegro Diagnostics, Inc. (acquired by Veracyte, NASDAQ: VCT). Specialties: Venture Capital, Healthcare, LifeSciences